Manage Your Liver
Q:

Hepatitis B: Maintaining normal ALT level can prevent lifelong medication treatment

Hepatitis B: Maintaining normal ALT level can prevent lifelong medication treatment
A:

According to the treatment guidelines published by WHO (World Health Organisation) in 2015, antiviral therapy is not recommended for hepatitis B patients with persistently normal ALT levels regardless of age. [1] Some patients may find this strange, why is antiviral treatment not recommended when virus is in their body?

 

This is because normal levels of ALT enzymes indicate that liver cells are not injured, and that there is no inflammation in the liver. So try to think of it the other way round, why would you require any medications when your liver is completely healthy? Rather than focusing on eliminating the virus from the body, the main objectives of treatment for hepatitis B patients should be to maintain a normal ALT level. Only this can guarantee that the liver is not damaged, and prevent liver fibrosis, cirrhosis or liver cancer. Patients should understand that the cause of these chronic diseases is not the virus itself, but the inflammation in the liver.

 

We recently received a blood test report from a YHK user. [2] This user has been using YHK for a number of years for liver protection. The blood test result shows that although the viral count of HBV is high, the ALT liver enzyme level remained normal. Many specialists advised this user not to take antiviral treatment after seeing persistently normal ALT levels results, and only recommended regular check-ups and monitoring. This is an example of the importance of normal ALT level, and also clearly shows that a high level of virus does not necessarily equals more liver damage.

 

Below are the user’s previous liver function test results:

Test Date ALT AST HBV DNA

2012-05-30

41 27

170,000,000 UI/ml

2012-09-10

24 18 -

2013-03-08

14 22

12,600,000 UI/ml

2014-02-14

13 17

588,000,000 UI/ml

2014-08-27

12 18

368,400,000 UI/ml

2015-03-10

12 20

403,200,000 UI/ml

2016-03-12

11 19

25,200,000 UI/ml

 * This user takes 4 YHK tablets per day.

 

 

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
With thousands of supplements in the market, and little regulations on supplements, finding a suitable one is difficult enough, let alone finding a SAFE one!   Here we will look at 5 things that you can look for when buying or using supplements, it can help you to avoid risky products and limited the chance of using something unsafe:   1. Look for registrations In some country, there are registration systems on suppl
A:
ALT (Alanine Aminotransferase / SGPT) is a type of enzyme found in liver cells. When the liver cells are functioning normally, the ALT enzymes should be contained within the liver cells.    You can imagine each liver cells as a balloon, and the ALT enzymes are the air inside the balloon. When the balloon is damaged, the air will be released. And when the liver cells is damaged, ALT enzymes are released into the bloodstream, therefore we are able to find out the l
Hit Questions
A:
YHK has significant effect in stopping liver inflammation; it can enhance the recovery of liver health and protect liver cells. Those who have experienced YHK often have these questions in mind: Why is YHK so different from other liver medicines and supplements? Why is it possible to have such unprecedented effects? The answer seems magical, but in fact, it is not complicated - Because YHK possesses a perfect balance.   To explain this, we must first point out that YH
A:
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
A:
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
A:
“It isn't fat but rather fibrosis that drives disease progression in people with advanced non-alcoholic steatohepatitis (NASH).”   NASH is one of the most prevalent liver diseases nowadays. NASH is related to non-alcoholic fatty liver disease (NAFLD) which is characterized by the buildup of fat in the liver. Although it is normal to have some fat in the liver, some people might develop inflammation because of this fat accumulation, this is cal
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us